Orphagen Pharmaceuticals
  • Home
  • Team
  • Pipeline
    • Pipeline
    • OR-449 for Oncology
    • OR-812 for IBD
    • RORβ Antagonists
  • Our Science
  • News
  • Contact
Select Page

ORPHAGEN PHARMACEUTICALS ANNOUNCES COLLABORATION AND LICENSE AGREEMENT WITH JAPAN TOBACCO INC.

by goldfishadmin | Jan 7, 2009 | News

Orphagen Pharmaceuticals, Inc., a privately held company (“Orphagen”) today announced that it has entered into a Collaboration and License Agreement with Japan Tobacco Inc., (“JT”) to discover, develop and commercialize drugs in the areas of immunology and...
Newer Entries »

News Archives

Search the Archives

Orphagen Pharmaceuticals, Inc.

9276 Sorrento Valley Rd
Suite 500
San Diego, CA 92121
+1-858-481-6191

For inquiries please contact info@orphagen.com

Designed by Elegant Themes | Powered by WordPress